文献速递脑血管病

估算多疗法降低复发性卒中风险的工具的推导与应用

Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk.
PubMed 文献 · Stroke · 2020-03-23

研究基于血压、胆固醇、抗血小板/抗凝及戒烟干预的相对风险,开发工具估算复发性卒中风险降低,并应用于一项随机试验的275名参与者。工具可行,估算实验组与常规组缺血性卒中相对风险降低均为0.36,两组平均可能避免45%的可预防复发事件。

要点

  • 工具可量化多危险因素改善对复发性卒中风险的联合影响。
  • 在试验中两组估计相对风险降低均为0.36。
  • 两组平均避免45%的最大可预防复发事件。

核心结论

  • 卒中风险降低工具有助于估算多危险因素改善对血管风险的联合影响,并为替代照护模式研究提供总结性结局。

研究设计与样本

  • 基于血压、降脂、抗血小板/抗凝及戒烟干预疗效证据提取相对风险,用自举法和模拟法开发工具。
  • 应用于一项随机试验中275名有完整12个月随访数据的参与者。

主要发现

  • 工具应用可行,实验组和常规组估计缺血性卒中相对风险降低均为0.36。
  • 修改版全局结局评分提示两组平均避免45%的最大可预防复发事件。

关键数值与推荐

  • 工具估算缺血性卒中相对风险降低0.36(实验组和常规组)。
  • 全局结局评分显示平均避免45%的可预防复发事件(两组)。

临床怎么用

  • 可用于替代照护模式研究中估算多危险因素改善对复发性卒中的联合影响。
  • 为低频率结局试验提供总结性结局指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. Methods- We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. Results- The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. Conclusions- A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. Registration- URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Richards A, Jackson NJ, Cheng EM, et al. Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk. Stroke. 2020. PMID: 32200759. doi:10.1161/STROKEAHA.119.027160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。